FDA Strips Breast Cancer Warning from Menopause Hormone Therapy

Scientific American — GlobalMonday, November 10, 2025 at 10:00:00 PM
The Food and Drug Administration (FDA) has reversed its previous stance by removing black box warnings from hormone replacement therapies used for menopause. This decision marks a significant change in the regulatory landscape for these treatments, which have been under scrutiny for potential health risks, including breast cancer.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it